Pearson Adds Computer-Based Treatment for Cognitive Impairments, RehaCom, to Family of Clinical Assessment and Intervention Solutions

Company partners with HASOMED to be exclusive North American reseller for evidence-based patient-centered intervention and rehabilitation solution
Publish date:
Social count:
Company partners with HASOMED to be exclusive North American reseller for evidence-based patient-centered intervention and rehabilitation solution

NEW YORK – May 16, 2016 – To support clinicians who treat the millions of people in the United States who suffer from traumatic brain injuries and other illnesses that result in cognitive impairment, Pearson today announced the addition of RehaCom to its comprehensive offering of tools to support neuropsychologists, speech-language pathologists and occupational therapists in their work with clients. As a result of an agreement with HASOMED GmbH, the developer of the evidence-based treatment for cognitive deficits, Pearson is now RehaCom’s exclusive distributor for North America.

Developed in 1988 – the early days of personal computing – by scientists at the University of Magdeburg in Germany, RehaCom was the first clinically tried and tested, computer-based training treatment for cognitive deficits. Having evolved through the collaboration of therapists and many scientific experts, today RehaCom is recognized as Europe’s leading system for computerized cognitive rehabilitation. Numerous studies from around the world demonstrate RehaCom’s efficacy in all phases of rehabilitation.

“In the more than 25 years since we developed RehaCom, millions of patients have benefited. This means that every day we have helped individuals recover from cognitive impairments and cope with everyday life once again,” said Peter Weber, D.Eng, CEO, HASOMED. “Now through our new partnership with Pearson, clinicians in North America will have the opportunity to use our proven, evidence-based treatment to support their work with clients dealing with cognitive deficits.”

RehaCom training is effective computer-based treatment for patients suffering from cognitive impairment due to traumatic brain injury, degenerative diseases and other illnesses or injuries. It provides clinicians with deficit-specific, targeted, evidence-based, patient-centered treatment that clients can work through with minimal supervision. Patient progress and gains are automatically tracked and monitored across a wide variety of cognitive domains, allowing clinicians to effectively and efficiently treat a larger client caseload, increasing both client treatment efficacy and clinician efficiency, resulting in strong return on investment for healthcare institutions. 

“Pearson is committed to offering clinicians treatment solutions that combine the power of today’s technology with a firm foundation in research to support them as they provide their clients with the most efficacious treatment possible,” said Aurelio Prifitera, Ph.D., managing director of Pearson’s clinical assessment group. “By growing our offerings, Pearson is developing a health care portfolio that provides solutions across the care continuum that ensures that patients receive the highest quality treatment, delivered affordably.”

For more information, visit


The name HASOMED stands for quality medical products and superior services. In collaboration with doctors, therapists and scientists, the company develops solutions for neurological rehabilitation and for the prophylaxis and therapy of neurodegenerative diseases. Research and development are firmly anchored in HASOMED’s corporate philosophy. For 25 years, HASOMED’s RehaCom has supported the rehabilitation of brain-injured individuals. Today RehaCom is the market leader in computer-assisted cognitive rehabilitation and is distributed worldwide in 18 languages. For more information,

About Pearson

Pearson is the world’s learning company, with expertise in educational courseware and assessment, and a range of teaching and learning services powered by technology. Our mission is to help people make progress through access to better learning. We believe that learning opens up opportunities, creating fulfilling careers and better lives.

Pearson’s Clinical Assessment group provides a comprehensive portfolio of research-based instruments to help clinicians develop insights that support evaluations and shape treatment plans. For more information about Pearson Clinical Assessment visit



New Webinar Series From Pearson Focuses on Working Memory Training promo image

New Webinar Series From Pearson Focuses on Working Memory Training

Pearson announced a series of webinars to provide clinicians and educators with a deeper understanding of working memory and approaches for helping individuals improve it. Centered on Cogmed, Pearson’s evidence-based, computerized working memory training program, the series explores the numerous effects of working memory deficits and ways to make improvements.

Pearson Connects Digital Solution for Response to Intervention to Common Core Math

Powerful RTI Assessment Tool, AIMSweb, Now Links to Lessons in enVisionMATH Common Core and focusMATH Intensive Intervention ProgramsBLOOMINGTON, Minn. – April 10, 2012 – To support the growing number of elementary schools turning to Response to Intervention (RTI) to ensure that students are on the path to academic success, Pearson today announced the pairing ofAIMSweb®, its powerful web-based benchmark and progress monitoring system, with enVisionMATH Common Core, a print and digital curriculum for students in kindergarten through grade 6, and focusMATH Intensive Intervention, an intensive, K-6 math intervention program. Students in schools teaching with these programs will now have their AIMSweb math results linked to recommended lessons in enVisionMATH Common Core as well as exercises in focusMATH Intensive Intervention, providing them with immediate practice on concepts and skills that they may be struggling to understand.